What does the OMW measure focus on in relation to Medicare women?

The measure focusing on the percentage of women who had a bone mineral density (BMD) scan or received osteoporosis treatment after experiencing a fracture is crucial for assessing healthcare quality in the Medicare population. This measure specifically targets the management of osteoporosis, a condition that is prevalent among older women, particularly post-menopausal individuals. Given that fractures can significantly impact the quality of life and health outcomes for these women, monitoring the follow-up care—through BMD scans or treatments after a fracture—is a vital aspect of preventive and responsive healthcare.

This measure reflects the importance of proactive management of osteoporosis, ensuring appropriate assessments and treatment pathways are available for women who are at risk or have already experienced a fracture. Effective management can lead to better health outcomes and decreased risk of further fractures, which is critical for maintaining mobility and independence in older adults.